Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leap Therapeutics
Biotech
Leap jumps from bio to crypto after winding down cancer program
Who would have predicted that one of the hottest trends for beleaguered biotechs in 2025 would be to rebrand as a crypto company?
James Waldron
Nov 12, 2025 10:44am
Biopharma layoffs hit 4-year monthly high in May
Jul 8, 2025 2:26pm
Leap expands layoffs to 75% of staff, scraps last clinical trial
Jun 23, 2025 9:22am
Leap halves head count amid 'difficult market environment'
May 13, 2025 9:10am
Leap crashes as midphase data mark end of gastric cancer program
Jan 28, 2025 8:31am
BeiGene lets option on Leap’s immuno-oncology candidate lapse
Mar 17, 2023 8:50am
